Dogan, S. Et Al. 2024. Does anxiety, depression, and sleep levels affect the quality of life in patients diagnosed with multiple sclerosis?. European review for medical and pharmacological sciences , vol.28, no.4 , 1306-1313.

Dogan, S., Yildiz, S., Kazgan Kılıçaslan, A., Sirlier Emir, B., Kurt, O., & Sehlikoğlu, S., (2024). Does anxiety, depression, and sleep levels affect the quality of life in patients diagnosed with multiple sclerosis?. European review for medical and pharmacological sciences , vol.28, no.4, 1306-1313.

Dogan, S Et Al. "Does anxiety, depression, and sleep levels affect the quality of life in patients diagnosed with multiple sclerosis?," European review for medical and pharmacological sciences , vol.28, no.4, 1306-1313, 2024

Dogan, S Et Al. "Does anxiety, depression, and sleep levels affect the quality of life in patients diagnosed with multiple sclerosis?." European review for medical and pharmacological sciences , vol.28, no.4, pp.1306-1313, 2024

Dogan, S. Et Al. (2024) . "Does anxiety, depression, and sleep levels affect the quality of life in patients diagnosed with multiple sclerosis?." European review for medical and pharmacological sciences , vol.28, no.4, pp.1306-1313.

@article{article, author={S Dogan Et Al. }, title={Does anxiety, depression, and sleep levels affect the quality of life in patients diagnosed with multiple sclerosis?}, journal={European review for medical and pharmacological sciences}, year=2024, pages={1306-1313} }